期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 478, 期 1, 页码 383-389出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2014.11.048
关键词
Mucoadhesion; Hyaluronic acid; Preactivated thiomers; Thiomers; Vaginal delivery
资金
- FWF (Fonds zur Forderung der wissenschaftlichen Forschung) [P23515 - B11]
- Austrian Science Fund (FWF) [P23515] Funding Source: Austrian Science Fund (FWF)
- Austrian Science Fund (FWF) [P 23515] Funding Source: researchfish
The objective of this study was to develop mucoadhesive polymeric excipients for vaginal drug delivery systems. Hyaluronic acid was thiolated and subsequently preactivated with 6-mercaptonicotinamide (HA-CYS-MNA) to enhance stability and mucoadhesive properties on vaginal mucosa. After determination of the thiol group content, disintegration studies and in vitro mucoadhesion studies (rotating cylinder and tensile) were performed. Furthermore, swelling behavior and cytotoxicity studies were performed in comparison with corresponding polymers. Both, disintegration and in vitro mucoadhesive studies revealed that modifying HA-CYS with MNA resulted in higher stability (3.6-fold prolonged disintegration time compared to unmodified hyaluronic acid) and prolonged mucoadhesion time. MTT assay and LDH revealed no toxicity for the polymeric excipients and safe for their use. Disintegration and swelling results conducted more pronounced stability of the preactivated thiomers compared to corresponding unmodified ones. According to these results preactivated hyaluronic acid might be a useful tool for vaginal delivery systems. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据